Seattle Children’s Therapeutics, a venture at Seattle Children’s, bringing cutting edge, curative technologies and therapies…
dcorriganMarch 10, 2022
The Fbw7 ubiquitin ligase targets many proteins for proteasomal degradation, which include oncogenic transcription factors…
dcorriganMarch 9, 2022
Recent molecular findings offer new details on how Nipah and Hendra viruses attack cells, and…
dcorriganMarch 8, 2022
As part of a massive nationwide effort to understand the condition commonly known as long…
dcorriganMarch 7, 2022
By combining CRISPR technology with a protein designed with artificial intelligence, it is possible to…
dcorriganMarch 4, 2022
Cryo-ET of Env on Intact HIV Virions Reveals Structural Variation and Positioning on the Gag Lattice
HIV-1 Env mediates viral entry into host cells and is the sole target for neutralizing…
dcorriganMarch 4, 2022
Cancer cells carry a lot of genetic hiccups that can help them outgrow normal surrounding…
dcorriganMarch 4, 2022
AltPep, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid…
dcorriganMarch 3, 2022
